相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma
Ruth Berthold et al.
ONCOGENESIS (2022)
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Benjamin A. Nacev et al.
NATURE COMMUNICATIONS (2022)
Critical role of the BAF chromatin remodeling complex during murine neural crest development
Kathleen Wung Bi-Lin et al.
PLOS GENETICS (2021)
SWI/SNF Component BAF250a Coordinates OCT4 and WNT Signaling Pathway to Control Cardiac Lineage Differentiation
Ienglam Lei et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma
Ilka Isfort et al.
CLINICAL CANCER RESEARCH (2019)
Control of cellular responses to mechanical cues through YAP/TAZ regulation
Ishani Dasgupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
Ilka Isfort et al.
SCIENTIFIC REPORTS (2019)
The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma
Matthew J. McBride et al.
CANCER CELL (2018)
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ
Lei Chang et al.
NATURE (2018)
Analysis of mutations in primary and metastatic synovial sarcoma
Zhuo Xing et al.
Oncotarget (2018)
Transcriptional Co-activator Functions of YAP and TAZ Are Inversely Regulated by Tyrosine Phosphorylation Status of Parafibromin
Chao Tang et al.
ISCIENCE (2018)
Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states
Cigall Kadoch et al.
NATURE GENETICS (2017)
The regulation of β-catenin activity and function in cancer: therapeutic opportunities
Shuang Shang et al.
ONCOTARGET (2017)
Wnt/β-catenin signaling via Axin2 is required for myogenesis and, together with YAP/Taz and Tead1, active in IIa/IIx muscle fibers
Danyil Huraskin et al.
DEVELOPMENT (2016)
Primary Metastatic Synovial Sarcoma: Experience of the CWS Study Group
Monika Scheer et al.
PEDIATRIC BLOOD & CANCER (2016)
The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma
Luisa Cironi et al.
SCIENTIFIC REPORTS (2016)
Synovial Sarcoma: Recent Discoveries as a Roadmap to New Avenues for Therapy
Torsten O. Nielsen et al.
CANCER DISCOVERY (2015)
β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition
Jared J. Barrott et al.
ONCOTARGET (2015)
A review: molecular aberrations within Hippo signaling in bone and soft-tissue sarcomas
Michael D. Deel et al.
FRONTIERS IN ONCOLOGY (2015)
Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)
A. Ferrari et al.
ANNALS OF ONCOLOGY (2015)
SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier
Sakura Tamaki et al.
PLOS ONE (2015)
Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
Gyu-Beom Jang et al.
SCIENTIFIC REPORTS (2015)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
Luca Azzolin et al.
CELL (2014)
Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer-Mechanisms and Potential Therapeutic Insights
Xiaofeng Wang et al.
CLINICAL CANCER RESEARCH (2014)
Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice
Junyan Tao et al.
GASTROENTEROLOGY (2014)
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma
M. Trautmann et al.
ONCOGENE (2014)
The Hippo Transducer TAZ Interacts with the SWI/SNF Complex to Regulate Breast Epithelial Lineage Commitment
Adam Skibinski et al.
CELL REPORTS (2014)
SRC Signaling Is Crucial in the Growth of Synovial Sarcoma Cells
Sebastian Michels et al.
CANCER RESEARCH (2013)
Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
Cigall Kadoch et al.
CELL (2013)
Targeting the Wnt Pathway in Synovial Sarcoma Models
Whitney Barham et al.
CANCER DISCOVERY (2013)
Role of TAZ as Mediator of Wnt Signaling
Luca Azzolin et al.
CELL (2012)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size
Todd Heallen et al.
SCIENCE (2011)
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region
Antoine Lurkin et al.
BMC CANCER (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
Mutational analysis of E-cadherin, beta-catenin and APC genes in synovial sarcomas
Manish Mani Subramaniam et al.
HISTOPATHOLOGY (2010)
Telomerase modulates Wnt signalling by association with target gene chromatin
Jae-Il Park et al.
NATURE (2009)
The synovial sarcoma translocation protein SYT-SSX2 recruits β-catenin to the nucleus andassociates with it in an active complex
D. Pretto et al.
ONCOGENE (2006)
Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital
EL Spurrell et al.
ANNALS OF ONCOLOGY (2005)
The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation
JB Wang et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Fusions of the SYT and SSX genes in synovial sarcoma
M Ladanyi
ONCOGENE (2001)
分享论文
